問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Pediatrics

Division of Neurology

更新時間:2023-09-19

林典佑
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

14Cases

2025-10-15 - 2032-12-31

Phase III

Not yet recruiting
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease
  • Condition/Disease

    Parkinson's Disease

  • Test Drug

    Injectable

Participate Sites
5Sites

Recruiting5Sites

2024-10-10 - 2026-10-13

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2022-06-01 - 2023-09-06

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2022-06-01 - 2027-10-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Not yet recruiting7Sites

2021-01-01 - 2029-07-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2023-05-01 - 2027-06-24

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
12Sites

Recruiting12Sites

2023-03-01 - 2025-09-09

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Not yet recruiting6Sites

2021-11-01 - 2029-03-18

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2023-07-01 - 2031-10-30

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2019-03-28 - 2029-04-06

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

1 2